Form 4: NeuroPace CFO Rebecca Kuhn Reports Acquisition of Common Stock and Stock Options

NeuroPace's Chief Financial Officer, Rebecca Kuhn, reported the acquisition of 12,500 shares of common stock and 24,950 stock options.

Summary

• On February 27, 2024, Rebecca Kuhn, the Chief Financial Officer of NeuroPace Inc., reported acquiring 12,500 shares of common stock represented by restricted stock units (RSUs) at $0.00 per share.
• Kuhn also acquired 24,950 stock options with an exercise price of $17.11.
• Following these transactions, Kuhn directly owns 152,204 shares of common stock and 24,950 stock options.
• The RSUs vest 25% on February 27, 2025, and the remaining RSUs vest in twelve equal quarterly installments thereafter.
• 25% of the shares subject to the option vest on February 27, 2025, with the remaining shares vesting in thirty-six equal consecutive monthly installments thereafter.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard disclosure of insider transactions. The acquisition of shares and options by the CFO could be seen as a positive signal, but it's not definitively bullish.

Positives

• The acquisition of shares and options by the CFO could be interpreted as a sign of confidence in the company's future prospects.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track management's alignment with shareholder interests.

Stakeholder Impact

• Shareholders may view the CFO's acquisition of shares and options as a positive sign, indicating confidence in the company's future performance.

Key Dates